Company
Photys Therapeutics, Inc.
Photys Therapeutics is a proximity-based therapeutics company advancing a new generation of targeted protein modulation medicines.
Also known as Photys Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Waltham, MA, United States
- Legal name
- Photys Therapeutics, Inc
Record updated 29 September 2026
About
Photys Therapeutics is a proximity-based therapeutics company advancing a new generation of targeted protein modulation medicines. Through its proprietary PHICS™ and tPRIME™ platforms, together with deep expertise in PROTACs, Photys is building a pipeline of differentiated therapies for autoimmune, inflammatory, oncology, and cardiometabolic diseases.
Funding snapshot
- Total raised
- $75MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $75M2022-09-08
Funding rounds
- Series A
- $75M2022-09-08, Company stated